Anavex Life Sciences Corp (AVXL)

[XenaLives]

First time I've gotten useful info from Google's Chat Bot:

Some drugs that have been approved as part of an open-label extension (OLE) include: Radicava/Edaravone, Neudexta, Riluzole/Tiglutik.
The FDA approved Relyvrio (AMX0035) in 2022 for the treatment of ALS. Relyvrio is a combination of sodium phenylbutyrate and taurursodiol that can prevent nerve cell death by blocking stress signals.
In 2023, the FDA approved Qalsody (tofersen) for use to treat SOD1-ALS. Qalsody is the first drug developed for patients with a rare form of ALS caused by mutations in a gene called SOD1.